As quoted in the press release:
HMJR is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small capitalization companies involved in the cultivation, production and/or distribution of marijuana. Stocks held within the Index will generally have an initial market capitalization of at least $50 million and less than $500 million. It is expected that no issuer will represent more than 8% of the Index on each rebalance.
“We are very pleased to be included in this new ETF and have expectations that the share price and liquidity of companies like ours will be enhanced proportionately by the buying power of an ETF. This ETF was specifically constructed to incorporate companies with operations in certain U.S. states, where cannabis use has been legalized under state law. These were largely overlooked by most prior ETF offerings,” said Linda Sampson, CEO of Marapharm.